Deoxycholic Acid

GeriatricPediatric
  • TRADE NAME: Kybella (Kythera)
  • INDICATIONS: Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat
  • CLASS: Cytolytic
  • HALF-LIFE: N/A

FDA APPROVAL DATE: 04/29/2015

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

None known

PREGNANCY CATEGORY: N/A

Contra-indicated in the presence of infection at the injection sites.

Our database has 26 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OTHER.


Page last updated 04/06/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top